← Back to Search

Reduced High-Frequency Hearing for Speech Perception

N/A

Recruiting

Research Sponsored by Brian Monson

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Normal hearing range of 250-8000 Hz

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1

Awards & highlights

Study Summary

This trial looks at how well people can understand speech when it is filtered to remove high frequency sounds.

Who is the study for?

This trial is for people who have normal hearing within the range of 250-8000 Hz and are native speakers of American English. It's not suitable for those with any level of hearing loss or non-native speakers of American English.Check my eligibility

What is being tested?

The study is looking at how reducing high-frequency sounds (above the normal range) affects understanding speech. Participants will listen to speech that has been altered to remove these high frequencies to see if it changes their ability to understand what's being said.See study design

What are the potential side effects?

Since this trial involves listening exercises, there are no direct physical side effects expected from participating in this research.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My hearing is normal across all pitches.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Speech recognition or localization score

Trial Design

1Treatment groups

Experimental Treatment

Group I: Normal-hearing listenersExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

328 Previous Clinical Trials

177,816 Total Patients Enrolled

Brian MonsonLead Sponsor

Media Library

Reduced extended high-frequency audibility Clinical Trial Eligibility Overview. Trial Name: NCT05435989 — N/A

Low-Pass Filtering Speech Research Study Groups: Normal-hearing listeners

Low-Pass Filtering Speech Clinical Trial 2023: Reduced extended high-frequency audibility Highlights & Side Effects. Trial Name: NCT05435989 — N/A

Reduced extended high-frequency audibility 2023 Treatment Timeline for Medical Study. Trial Name: NCT05435989 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept geriatric patients?

"As outlined in the requirements for participation, participants must range between 19 and 50 years old."

Answered by AI

Are there any remaining vacancies to participate in the research?

"According to clinicaltrials.gov, this research project is not presently accepting patients; the trial was initially posted on November 9th 2021 and last updated July 28th 2022. Despite that, there are still 1 additional trials actively seeking candidates at present."

Answered by AI

What characteristics make a participant ideal for this research endeavor?

"This clinical trial seeks 480 patients aged 19-50 with native level fluency in American English. The study also requires that participants have normal hearing between 250-8000 Hz."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Extended High-frequency Hearing and Speech Perception

Brian Monson 2021. "Extended High-frequency Hearing and Speech Perception". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05435989.